Business · 11/04/2023Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for Pfizer's Respiratory Syncytial Virus Vaccine
Summary
The FDA is hosting a public meeting of the Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's application for a vaccine to prevent RSV in infants, and is seeking public comments on the proposal.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →